Intestinal microbiota and its relationship with diabetes and obesity

Clinical Diabetology

Volumn 5, Issue 5, 2016, Pages 164-172

  Pokrzywnicka, Patrycja ^a   Gumprecht, Janusz ^b  

^a Municipal Hospital   (Poland)

^b Diabetology and Nephrology ^*  (Poland)

Author keywords

Diabetes mellitus; Intestinal microbiota; Obesity; Prebiotics; Probiotics; Short chain fatty acids

Indexed keywords

ANGIOPOIETIN; BILE ACID; CARNITINE PALMITOYLTRANSFERASE; FARNESOID X RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 6; PEPTIDE YY; PREBIOTIC AGENT; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; VERY LOW DENSITY LIPOPROTEIN;

ACTINOBACTERIA; BACTERIAL GENOME; BACTERIAL METABOLISM; BACTEROIDETES; BIFIDOBACTERIUM; DYSBIOSIS; ENTEROBACTERIACEAE; FIRMICUTES; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTESTINAL MICROFLORA TRANSPLANTATION; INTESTINE FLORA; LACTOBACILLUS; LIPID STORAGE; MICROBIAL COLONIZATION; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEOBACTERIA; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS; TRANSPLANTATION;

EID: 85016065411     PISSN: 24507458     EISSN: 24508187     Source Type: Journal    
DOI: 10.5603/DK.2016.0029     Document Type: Review

References (64)

1. Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005; 1: 15-25.
2. DiBaise JK, Zhang H, Crowell MD et al. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 2008; 83: 460-469.
3. Turnbaugh PJ, Ley RE, Mahowald MA et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
4. Denechaud PD, Dentin R, Girard J, Postic C. Role of ChREBP in hepatic steatosis and insulin resistance. FEBS Lett 2008; 582: 68-73.
5. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002; 68: 219-226.
6. Pai R, Kang G. Microbes in the gut: A digestable account of hostsymbiont interactions. Indian J Med Res 2008; 128: 587-594.
7. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5: E177.
8. De Filippo C, Cavalieri D, Di Paola M et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107: 14691-14696.
9. Liszt K, Zwielehner J, Handschur M et al. Characterization of bacteria, clostridia and Bacteroides in faeces of vegetarians using qPCR and PCR-DGGE fingerprinting. Ann Nutr Metab 2009; 54: 253-257.
10. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: Human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
11. Arumugam M, Raes J, Pelletier E et al. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-180.
12. Kootte RS, Vrieze A, Holleman F et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 2012; 14: 112-120.
13. Benson AK, Kelly SA, Legge R et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci USA 2010; 107: 18933-18938.
14. Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. Gut microbiota and diabetes: From pathogenesis to therapeutic perspective. Acta Diabetol 2011; 48: 257-273.
15. Agans R, Rigsbee L, Kenche H et al. Distal gut microbiota of adolescent children is different from that of adults. FEMS Microbiol Ecol 2011; 77: 404-412.
16. Stachowicz N, Kiersztan A. Rola mikroflory jelitowej w patogenezie otylosci i cukrzycy typu 2. Postepy Hig Med Dosw 2013; 67: 288-303.
17. Shanahan F, Murphy E. The hybrid science of diet, microbes, and metabolic health. Am J Clin Nutr 2011; 94: 1-2.
18. Neu J, Douglas-Escobar M, Lopez M. Microbes and the developing gastrointestinal tract. Nutr Clin Pract 2007; 22: 174-182.
19. Enck P, Zimmermann K, Rusch K. The effects of maturation on the colonic microflora in infancy and childhood. Gastroenterol Res Pract 2009; 2009: 752401.
20. Tilg H, Moschen A, Kaser A. Obesity and the microbiota. Gastroenterology 2009; 136: 1476-1483.
21. Membrez M, Blancher F, Jaquet M et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 2008; 22: 2416-2426.
22. Zak-Golab A, Olszanecka-Glinianowicz M, Kocelak P, Chudek J. Rola flory jelitowej w patogenezie otylosci. Postepy Hig Med Dosw 2014; 68: 84-90.
23. Wilders-Trusching M, Mangge H, Lieners C et al. IgG Antibodies Against Food Antigens are correlated with inflammation and intima media thickness in obese juveniles. Exp Clin Endocrinol Diabetes (online) 2007.
24. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 2002; 99: 15451-15455.
25. Flint HJ, Bayer EA, Rincon MT, Lamed R. Polysaccharide utilization by gut bacteria: Potential for new insights from genomic analysis. Nat Rev Microbiol 2008; 6: 121-131.
26. Harris K, Kassis A, Major G, Chou CJ. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes 2012; 2012: 879151.
27. Wong JM, de Souza R, Kendall CW, Emam A. Colonic health: Fermentation and short chain fatty acids. J Clin Gastroenterol 2006; 40: 235-243.
28. Schwiertz A, Taras D, Schäfer K et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010; 18: 190-195.
29. Denechaud PD, Dentin R, Girard J, Postic C. Role of ChREBP in hepatic steatosis and insulin resistance. FEBS Lett 2008; 582: 68-73.
30. Nicholson JK, Holmes E, Kinross J et al. Host-gut microbiota metabolic interactions. Science 2012; 336: 1262-1267.
31. Gao Z, Yin J, Zhang J et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009; 58: 1509-1517.
32. Duncan SH, Belenguer A, Holtrop G et al. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 2007; 73: 1073-1078.
33. Bäckhed F, Crawford PA, O'Donnell D, Gordon JI. Postnatal lymphatic partitioning from the blood vasculature in the small intestine requires fasting-induced adipose factor. Proc Natl Acad Sci USA 2007; 104: 606-611.
34. Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005; 1: 15-25.
35. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009; 89: 147-191.
36. Swann JR, Want EJ, Geier FM et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA 2011; 108 (Suppl 1): 4523-4530.
37. Thomas C, Gioiello A, Noriega L et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009; 10: 167-177.
38. Dziewiatowska J, Janczy A, Steinka I, Pieszko M, Malgorzewicz S. Zwiazek pomiedzy mikroflora jelitowa a otyloscia. Forum Zab Metab 2014; 5: 20-25.
39. Levin BE, Keesey RE. Defense of differing body weight set points in diet-induced obese and resistant rats. Am J Physiol 1998; 274: 412-419.
40. Tappy L. Metabolic consequences of overfeeding in humans. Curr Opin Clin Nutr Metab Care 2004; 7: 623-628.
41. Zak-Golab A, Olszanecka-Glinianowicz M, Kocelak P, Chudek J. Rola flory jelitowej w patogenezie otylosci. Postepy Hig Med Dosw 2014; 68: 84-90.
42. Jumpertz R, Le DS, Turnbaugh PJ et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 2011; 94: 58-65.
43. Turnbaugh PJ, Ley RE, Mahowald MA et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
44. Farooqi IS, Bullmore E, Keogh J et al. Leptin regulates striatal regions and human eating behavior. Science 2007; 317: 1355.
45. Dumas ME, Barton RH, Toye A et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 2006; 103: 12511-12516.
46. Amar J, Burcelin R, Ruidavets J et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008; 87: 1219-1223.
47. Erridge C, Attina T, Spickett C et al. A high-fat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007; 86: 1286-1292.
48. Vijay-Kumar M, Aitken J, Carvalho F et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328: 228-231.
49. Amar J, Chabo C, Waget A et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: Molecular mechanisms and probiotic treatment. EMBO Mol Med 2011; 3: 559-572.
50. Saberi M, Woods N, de Luca C et al. Hematopoietic cell-specific deletion of Toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance. Cell Metab 2009; 10: 419-429.
51. Cani PD, Bibiloni R, Knauf C et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-1481.
52. Frank DN, St Amand AL, Feldman RA et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104: 13780-13785.
53. Larsen N, Vogensen FK, van der Berg FW et al. Gut microbiota in human adults with type 2 diabetes divers from non-diabetic adults. PLoS One 2010; 5: 9085.
54. Claesson MJ, Cusack S, O'Sullivan O et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 2011; 108 (Suppl 1): 4586-4591.
55. Brugman S et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 2006; 49: 2105-2108.
56. Delzenne NM, Cani PD, Daubioul C, Neyrinck AM. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 2005; 93 (Suppl 1): S157-S161.
57. Vilsbøll T, Krarup T, Madsbad S, Holst JJ. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul Pept 2003; 114: 115-121.
58. Cani PD, Neyrinck AM, Fava F et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50: 2374-2383.
59. Archer BJ, Johnson SK, Devereux HM, Baxter AL. Effect of fat replacement by inulin or lupin-kernel fibre on sausage patty acceptability, post-meal perceptions of satiety and food intake in men. Brit J Nutr 2004; 91: 591-599.
60. Muccioli GG, Naslain D, Bäckhed F et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 2010; 6: 392.
61. Marlicz W, Ostrowska L, Loniewski I. Flora bakteryjna jelit i jej potencjalny zwiazek z otyloscia. Endokrynologia, Otylosc i Zaburzenia Przemiany Materii 2013; 9: 20-28.
62. Andreasen A, Larsen N, Pedersen-Skovsgaard T et al. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 2010; 104: 1831-1838.
63. Kadooka Y, Sato M, Imaizumi K et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 2010; 64: 636-643.
64. Ostrowska L, Marlicz W, Loniewski I. Transplantacja mikroflory jelitowej w leczeniu otylosci i zaburzen metabolicznych. Forum Zab Metab 2013; 4: 161-169.